Upal Basu Roy, PhD, MPH, discusses the challenges of interpreting molecular testing results in lung cancer.
Upal Basu Roy, PhD, MPH
Advertisement
Articles by Upal Basu Roy, PhD, MPH
Upal Basu Roy, PhD, MPH, discusses addressing barriers to biomarker testing in lung cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings
3
META 10-19 Elicits High Complete Response Rate at Ultra-Low Doses in High-Risk R/R DLBCL
4
Sonrotoclax and Next-Generation BCL-2 Inhibitors for Treating CLL
5